Page last updated: 2024-08-21

pyrazines and Thrombocythemia

pyrazines has been researched along with Thrombocythemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Banti, A; Kaloutsi, V; Lazaridou, A; Terpos, E; Verrou, E; Zervas, K	1

Other Studies

1 other study(ies) available for pyrazines and Thrombocythemia

Article	Year
Bortezomib is an effective agent for MDS/MPD syndrome with 5q- anomaly and thrombocytosis. Leukemia research, 2007, Volume: 31, Issue:4 Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Chromosomes, Human, Pair 5; Female; Humans; Interleukin-4; Interleukin-6; Middle Aged; Myelodysplastic Syndromes; Myeloproliferative Disorders; Platelet Count; Pyrazines; Thrombocytosis; Tumor Necrosis Factor-alpha	2007

Article

Year

Bortezomib is an effective agent for MDS/MPD syndrome with 5q- anomaly and thrombocytosis.

Leukemia research, 2007, Volume: 31, Issue:4

Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Chromosomes, Human, Pair 5; Female; Humans; Interleukin-4; Interleukin-6; Middle Aged; Myelodysplastic Syndromes; Myeloproliferative Disorders; Platelet Count; Pyrazines; Thrombocytosis; Tumor Necrosis Factor-alpha

2007